The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's disease
Abstract
The cause and mechanism of neuronal cell death in the substantia nigra of patients with Parkinson's disease (PD) are unknown. There is also controversy about whether the cell death results from a single event followed by cell loss consistent with aging or whether there is an ongoing pathologic process. Using postmortem tissue obtained from the Parkinson's Disease Society Brain Tissue Bank in London, we have sought to establish whether apoptosis, or more specifically DNA fragmentation of neurons, is a prominent feature of nigral pathology. In addition, we have studied microglial activation in the substantia nigra as an indicator of ongoing pathology using the highly sensitive markers CR3/43 and EBM11. Reactive astrocytes have been assessed using immunostaining for glial fibrillary acidic protein (GFAP). Ten patients with pathologically proven PD were studied. In all cases, regardless of disease duration, severity, drug treatment, or age of the patient, there was no evidence of apoptosis in the substantia nigra as assessed by in situ end‐labeling of DNA fragments using biotinylated dUTP and terminal deoxynucleotidyl transferase (TdT). In contrast, a case of multiple system atrophy (MSA) served as a positive control for the technique. In this case, positive DNA end‐labeling could be found in neurons and non‐neuronal cells in the brain stem. In the PD cases, there was, however, localized pathology in the substantia nigra as revealed by the CR3/43 and EBM11 markers for activated microglia. This process seemed independent of disease duration and was florid even in patients with severe neuronal loss. It remains to be determined to what extent the activation of glial cells reflects progressive nigral pathology, and whether those factors which are classically associated with prominent apoptotic neuronal cell death in vivo, such as neurotrophic factor deprivation, are prime causes of nigral neuronal loss in PD. Future studies should focus on recent‐onset PD or incidental Lewy body disease to further address these questions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell Death: The Significance of Apoptosis
Wyllie, A. H., Kerr, J. F. R., & Currie, A. R. (1980) · International Review of Cytology · doi:10.1016/s0074-7696(08)62312-8 · Cited by 7,162
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Increased nigral iron content in postmortem parkinsonian brain
Dexter, D. T., Wells, F. R., Agid, F., Agid, Y., Lees, A. J., Jenner, P., & Marsden, C. D. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91361-4 · Cited by 963
CENTRAL CERVICAL CORD SYNDROME AFTER HEADING A FOOTBALL
Scoppetta, C., & Vaccario, M. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92517-5 · Cited by 753
Gold, R., Schmied, M. C., Giegerich, G., Breitschopf, H., Hartung, H., Toyka, K. V., & Lassmann, H. (1994) · PubMed · Cited by 675
Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models
Portera-Cailliau, C., Hedreen, J., Price, D., & Koliatsos, V. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-03775.1995 · Cited by 607
Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ
Lassmann, H., Bancher, C., Breitschopf, H., Wegiel, J., Bobinski, M., Jellinger, K., & Wisniewski, H. M. (1995) · Acta Neuropathologica · doi:10.1007/bf00294257 · Cited by 458
Oxidative damage in neurodegenerative disease
Jenner, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92347-7 · Cited by 418
Complex I Inhibitors Induce Dose‐Dependent Apoptosis in PC12 Cells: Relevance to Parkinson's Disease
Hartley, A., Stone, J. M., Heron, C., Cooper, J. M., & Schapira, A. H. V. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63051987.x · Cited by 361
Walkinshaw, G., & Waters, C. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117946 · Cited by 240
Ziv, I., Melamed, E., Nardi, N., Luria, D., Achiron, A., Offen, D., & Barzilai, A. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90258-5 · Cited by 221
MIGHELI, A., CAVALLA, P., MARINO, S., & SCHIFFER, D. (1994) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199411000-00008 · Cited by 205
Surveillance, Intervention and Cytotoxicity: Is There a Protective Role of Microglia?
Banati, R. B., & Graeber, M. B. (1994) · Developmental Neuroscience · doi:10.1159/000112098 · Cited by 184
Self-citationGraeber, M. B., Streit, W. J., Büringer, D., Sparks, D. L., & Kreutzberg, G. W. (1992) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199205000-00009 · Cited by 149
Gehrmann, J., & Banati, R. B. (1995) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199509000-00010 · Cited by 148
Self-citationCR3/43, a marker for activated human microglia: application to diagnostic neuropathology
Graeber, M. B., Bise, K., & Mehraein, P. (1994) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1994.tb00987.x · Cited by 90
Is idiopathic parkinsonism the consequence of an event or a process?
Calne, D. B. (1994) · Neurology · doi:10.1212/wnl.44.1.5 · Cited by 90
Research works printed but not linked: 3
- Forno LS, 1971, Recent Advances in PD, 120
- Anglade P, 1996, Apoptotic degeneration of nigral dopaminergic neurons in Parkinson's disease [Abstract], Neurology, 46, A467
- Morrish PK, 1994, The rate of progression of PD: a longitudinal 18F‐DOPA PET study [Abstract], Journal of Neurochemistry, 8, 198
Cited by
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
Blum, D., Torch, S., Lambeng, N., Nissou, M.-F., Benabid, A.-L., Sadoul, R., & Verna, J.-M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00003-x · Cited by 1,246
Middeldorp, J., & Hol, E. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.005 · Cited by 1,080
Tansey, M. G., & Goldberg, M. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.004 · Cited by 1,045
Metadata
- Authors
- Banati, R. B., Daniel, S. E., & Blunt, S. B.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 1998-03
- Volume
- 13
- Issue
- 2
- Pages
- 221-227
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2011850283
- Cited by
- 431
- References
- 19
- FWCI
- 11.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.